<?xml version="1.0" encoding="UTF-8"?>
<p>The clinical course of COPD, as well as that of asthma, is punctuated by exacerbations, which are characterized by sudden symptom worsening beyond the expected daily variation. Exacerbations are important events in the clinical course of COPD, because they are associated with significant mortality. The in-hospital mortality rate of patients admitted to the hospital with exacerbations of COPD was 8%, increasing to 23% after 1 year of follow-up (
 <xref ref-type="bibr" rid="B33">Groenewegen et al., 2003</xref>). Exacerbations are correlated with accelerated loss of lung function and quality of life and increased healthcare costs (
 <xref ref-type="bibr" rid="B96">Seemungal et al., 1998</xref>; 
 <xref ref-type="bibr" rid="B24">Donaldson et al., 2002</xref>; 
 <xref ref-type="bibr" rid="B71">Miravitlles et al., 2002</xref>).
</p>
